4-(1-Benzo[1,3]dioxol-5-ylmethyl-piperidin-4-ylamino)-6-chloro-chromen-2-one

ID: ALA194564

Cas Number: 638191-35-2

PubChem CID: 10047339

Max Phase: Preclinical

Molecular Formula: C22H21ClN2O4

Molecular Weight: 412.87

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  O=c1cc(NC2CCN(Cc3ccc4c(c3)OCO4)CC2)c2cc(Cl)ccc2o1

Standard InChI:  InChI=1S/C22H21ClN2O4/c23-15-2-4-19-17(10-15)18(11-22(26)29-19)24-16-5-7-25(8-6-16)12-14-1-3-20-21(9-14)28-13-27-20/h1-4,9-11,16,24H,5-8,12-13H2

Standard InChI Key:  FBKMRPXQTLKWBJ-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 29 33  0  0  0  0  0  0  0  0999 V2000
    3.5667   -3.7125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2875   -4.1250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8542   -4.1250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2875   -4.9500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8542   -4.9500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5667   -5.3625    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.5667   -2.8875    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.7125   -1.6417    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.7167    0.8458    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4292    1.2583    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1000    1.3958    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.1417   -3.7125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2625    2.0708    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.4375    2.1583    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7167    0.0208    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0042   -5.3667    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.4292   -0.3917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1417   -5.3625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4292   -1.2250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2792   -2.4750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1417    0.8458    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2792   -1.6500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9917   -2.8917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7125   -2.4750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9917   -1.2292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4292   -4.1250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1417    0.0208    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4292   -4.9500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7042   -3.7125    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  1  1  0
  4  2  1  0
  5  3  1  0
  6  5  1  0
  7  1  1  0
  8 24  1  0
  9 15  2  0
 10 21  2  0
 11  9  1  0
 12  3  2  0
 13 10  1  0
 14 11  1  0
 15 17  1  0
 16  4  2  0
 17 19  1  0
 18  5  2  0
 19  8  1  0
 20  7  1  0
 21 27  1  0
 22 20  1  0
 23 20  1  0
 24 23  1  0
 25 22  1  0
 26 12  1  0
 27 17  2  0
 28 26  2  0
 29 26  1  0
  4  6  1  0
  8 25  1  0
 28 18  1  0
 10  9  1  0
 14 13  1  0
M  END

Associated Targets(Human)

MCHR1 Tchem Melanin-concentrating hormone receptor 1 (5587 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KCNH2 Tclin HERG (29587 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRA1A Tclin Adrenergic receptor alpha-1 (948 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DRD2 Tclin Dopamine receptor (115 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Rattus norvegicus (775804 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 412.87Molecular Weight (Monoisotopic): 412.1190AlogP: 4.25#Rotatable Bonds: 4
Polar Surface Area: 63.94Molecular Species: NEUTRALHBA: 6HBD: 1
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 7.93CX LogP: 2.80CX LogD: 2.16
Aromatic Rings: 3Heavy Atoms: 29QED Weighted: 0.65Np Likeness Score: -0.82

References

1. Kym PR, Iyengar R, Souers AJ, Lynch JK, Judd AS, Gao J, Freeman J, Mulhern M, Zhao G, Vasudevan A, Wodka D, Blackburn C, Brown J, Che JL, Cullis C, Lai SJ, LaMarche MJ, Marsilje T, Roses J, Sells T, Geddes B, Govek E, Patane M, Fry D, Dayton BD, Brodjian S, Falls D, Brune M, Bush E, Shapiro R, Knourek-Segel V, Fey T, McDowell C, Reinhart GA, Preusser LC, Marsh K, Hernandez L, Sham HL, Collins CA..  (2005)  Discovery and characterization of aminopiperidinecoumarin melanin concentrating hormone receptor 1 antagonists.,  48  (19): [PMID:16161992] [10.1021/jm050598r]

Source